Resources
Paper
Budesonide versus prednisolone retention enemas in active distal ulcerative colitis
Lofberg R, Ostergaard Thomsen O, Langholz E et al. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Aliment Pharmacol Ther. 1994;8:623-629.
Paper
A Comparison of Budesonide with Prednisolone for Active Crohn’s Disease
Rutgeerts P, Lofberg R, Malchow H et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med. 1994;331:842-845.
Paper
A comparison of budesonide with prednisolone for active Crohn’s disease
Rutgeerts P, Lofberg R, Malchow H et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med. 1994;331:842-845.
Paper
Immune modulating therapies for idiopathic inflammatory bowel disease. Adv Pharmacol
Levine, DS. Immune modulating therapies for idiopathic inflammatory bowel disease. Adv Pharmacol. 1994;25:171-234.
Paper
Ricin: structure, mode of action, and some current applications
Lord, J.M., L.M. Roberts, and J.D. Robertus, Ricin: structure, mode of action, and some current applications. FASEB J, 1994. 8(2): p. 201-8.
Paper
Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo
Lemley, P.V., P. Amanatides, and D.C. Wright, Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo. Hybridoma, 1994. 13(5): p. 417-21.
Paper
The in vivo behaviour of a colonic delivery system: a pilot study in man
Steed KP, Hooper G, Ventura P et al. The in vivo behaviour of a colonic delivery system: A pilot study in man. Int J Pharm. 1994;112:199-206
Paper
Immune modulating therapies for idiopathic inflammatory bowel diseases
Levine, DS. Immune modulating therapies for idiopathic inflammatory bowel disease. Adv Pharmacol. 1994;25:171-234.
Paper
Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndrome
Soler-Rodriguez, A.M., et al., Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndrome. Exp Cell Res, 1993. 206(2): p. 227-34.
Paper
Protection of mice from inhaled ricin by vaccination with ricin or by passive treatment with heterologous antibody
Hewetson, J.F., et al., Protection of mice from inhaled ricin by vaccination with ricin or by passive treatment with heterologous antibody. Vaccine, 1993. 11(7): p. 743-6.